Viewing Study NCT02181335


Ignite Creation Date: 2025-12-24 @ 10:41 PM
Ignite Modification Date: 2026-02-21 @ 4:08 AM
Study NCT ID: NCT02181335
Status: COMPLETED
Last Update Posted: 2014-07-18
First Post: 2014-07-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module